TNF and Alzheimer disease: In agreement with our observation, several anti-TNF-α medications have decreased Aβ deposition, cognitive injury and inflammatory response in AD animal models (Russo et al., 2012; Tweedie et al., 2012; Detrait et al., 2014; Gabbita et al., 2015).